Both companies utilize DARPA associated technologiesFREDERICK, Md., Jan. 12, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ),...
- Fast Track Designation granted from U.S. Food and Drug Administration for PRA023 for the treatment of Systemic Sclerosis-Associated Interstitial...
On October 6, 2021, GN announced an agreement to acquire SteelSeries - a global pioneer in premium software-enabled gaming gear....
FLORHAM PARK, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Acquisition of Cleared Further Diversifies LifeMD’s Telehealth Offerings to Encompass Allergy, Asthma, and Immunology Acquisition Expected to Synergize with LifeMD Virtual...
In business for 20 years, Body Energy Club is the leading health supplement and vitamin retailer in Western Canada, with...
Positive Data Support the Durability and Cost-Effectiveness of Deep TMS as a Treatment for Obsessive-Compulsive DisorderBURLINGTON, Mass. and JERUSALEM, Israel,...
nVNS reduces symptoms of PTSD by 31% in sham-controlled studyROCKAWAY, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR),...
BURNABY, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that...
MIAMI, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company...
IMX-110 Surpasses Standard of Care in Mice Cancer Study Immix Biopharma, Inc. (NASDAQ:IMMX) IMX-110 produced a 50% response rate after...
Data demonstrates that PTX-35 may have utility in solid organ transplantation, and to potentially slow or mitigate deleterious immune responses...
EDISON, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- It is with profound sadness that Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) announces the...
Cary, NC, Jan. 12, 2022 (GLOBE NEWSWIRE) -- APIE Therapeutics, a preclinical biopharma company pioneering microvasculature endothelium drug development by...
- Phase 1 multiple ascending dose data for CRN04894 and CRN04777 expected in 1Q 2022 – - Initiation of patient...
CINCINNATI, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based...
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, January 19, 2022 at 4:30 p.m. ET CELEBRATION,...
English and Chinese Sessions to be Held to Accommodate Multiple Time ZonesFOSTER CITY, Calif., SHANGHAI and HANGZHOU, China, Jan. 12,...
For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V,...
Wesana granted pre-IND meeting with FDA, currently set for March 11, 2022Wesana Clinics exhibited a record quarter of billings, new...
